Z. Szalai

M. Socinski, S. Novello, F. Barlesi, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Differential scanning calorimetry (DSC) of blood serum in chronic obstructive pulmonary disease (COPD)

D. Lőrinczy, T. Molnar, Z. Szalai, 2013, Journal of Thermal Analysis and Calorimetry.

Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction

A. Lindberg, Z. Szalai, T. Pullerits, 2007, Respirology.

Comorbidity burden and survival in patients with idiopathic pulmonary fibrosis: the EMPIRE registry study

M. Kramer, L. Dušek, E. Jassem, 2022, Respiratory Research.

Prediction of Clinical and Mucosal Severity of Coeliac Disease and Dermatitis Herpetiformis by Quantification of IgA/IgG Serum Antibodies to Tissue Transglutaminase

I. Korponay-Szabó, M. Mäki, Z. Szalai, 2010, Journal of pediatric gastroenterology and nutrition.

COVID-19 mortality is associated with low vitamin D levels in patients with risk factors and/or advanced age

S. Jenei, T. Molnár, B. Büki, 2021, Clinical Nutrition ESPEN.

Herpes in STAT1 gain-of-function mutation

J. Casanova, Z. Tulassay, A. Puel, 2012, The Lancet.

COPD_A_291920 615..628

A. Valipour, J. Šorli, Z. Szalai, 2021 .

[Disease course, frequency of relapses and survival of patients with juvenile or adult dermatomyositis].

M. Garami, Z. Balogh, A. Ponyi, 2007, Orvosi hetilap.

National registry of patients with juvenile idiopathic inflammatory myopathies in Hungary—Clinical characteristics and disease course of 44 patients with juvenile dermatomyositis

M. Garami, Z. Balogh, A. Ponyi, 2006, Autoimmunity.

Numerical simulation of the effect of inhalation parameters, gender, age and disease severity on the lung deposition of dry powder aerosol drugs emitted by Turbuhaler®, Breezhaler® and Genuair® in COPD patients.

Z. Szalai, G. Gálffy, Á. Farkas, 2020, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

European guideline (EuroGuiDerm) on atopic eczema – part II: non‐systemic treatments and treatment recommendations for special AE patient populations

C. Flohr, T. Bieber, G. Girolomoni, 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

European guideline (EuroGuiDerm) on atopic eczema: part I – systemic therapy

C. Flohr, T. Bieber, G. Girolomoni, 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

Poststreptococcal glomerulonephritis and nasal symptoms: Wegener's granulomatosis

G. Katona, Z. Szalai, A. Czinner, 2011 .

Novel keratin 14 gene mutations in patients from Hungary with epidermolysis bullosa simplex

Z. Szalai, M. Csikós, S. Kárpáti, 2004, Experimental dermatology.

Topical corticosteroid phobia in atopic dermatitis: International feasibility study of the TOPICOP score

Å. Svensson, S. Barbarot, D. Murrell, 2017, Allergy.

Safety of Systemic Agents for the Treatment of Pediatric Psoriasis

D. West, K. Holland, J. Lambert, 2017, JAMA dermatology.

Disease course, frequency of relapses and survival of 73 patients with juvenile or adult dermatomyositis.

M. Garami, Z. Balogh, G. Borgulya, 2005, Clinical and experimental rheumatology.

PACAP Immunoreactivity in Human Malignant Tumor Samples and Cardiac Diseases

A. Tamas, D. Reglodi, B. Gaszner, 2012, Journal of Molecular Neuroscience.

European Task Force on Atopic Dermatitis statement on severe acute respiratory syndrome coronavirus 2 (SARS‐Cov‐2) infection and atopic dermatitis

C. Flohr, J. Ring, T. Bieber, 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

Tetraalkyl Hydroxymethylene-bisphosphonate and Dialkyl 1-Diphenylphosphinoyl-1-hydroxy-ethylphosphonate Derivatives by the Pudovik Reaction and Their Rearranged Products

G. Keglevich, Z. Szalai, 2021, Molecules.

Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II

A. Muraro, S. Lau, J. Ring, 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.

Establishment of relationships between native and inhalation device specific spirometric parameters as a step towards patient tailored inhalation device selection.

I. Horváth, A. Nagy, Z. Szalai, 2019, Respiratory medicine.

Infantile anogenital digitate keratoses: A case series of a novel entity

S. Greenberger, L. Horev, Z. Szalai, 2022, JAAD case reports.

Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I

A. Muraro, S. Lau, J. Ring, 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.

Infantile psoriasis: A short clinical study

Z. Szalai, E. Török, A. Sáringer, 2001 .

Dystrophic epidermolysis bullosa complicated by cutaneous squamous cell carcinoma and pulmonary and renal amyloidosis

L. Bruckner-Tuderman, L. Bruckner-Tuderman, Z. Szalai, 2003, Clinical and experimental dermatology.

The Arg160Trp Allele of Melanocortin‐1 Receptor Gene Might Protect Against Vitiligo †

L. Kemény, L. Bodai, A. Dobozy, 2008, Photochemistry and photobiology.

Identification of two novel nonsense mutations in the transglutaminase 1 gene in a Hungarian patient with congenital ichthyosiform erythroderma

Z. Szalai, M. Csikós, S. Kárpáti, 2003, Experimental dermatology.

Long-Term Outcomes and Retreatment Among Patients With Previously Treated, Programmed Death-Ligand 1‒Positive, Advanced Non‒Small-Cell Lung Cancer in the KEYNOTE-010 Study.

R. Herbst, S. Novello, G. Ceresoli, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[Observations on human parvovirus B19 infection diagnosed in 2011].

Z. Szalai, Z. Arányi, A. Marosi, 2012, Orvosi hetilap.

Propranolol for infantile haemangioma: striking effect in the first weeks.

G. Katona, Z. Szalai, Zsuzsanna Csákányi, 2012, International journal of pediatric otorhinolaryngology.

Genetic dissection between coeliac disease and dermatitis herpetiformis in sib pairs

I. Korponay-Szabó, J. Partanen, K. Mustalahti, 2002 .

OA05.07 IMpower132: PFS and Safety Results with 1L Atezolizumab + Carboplatin/Cisplatin + Pemetrexed in Stage IV Non-Squamous NSCLC

S. Novello, V. Papadimitrakopoulou, P. Dubray-Longeras, 2018, Journal of Thoracic Oncology.

Tacrolimus ointment does not affect the immediate response to vaccination, the generation of immune memory, or humoral and cell-mediated immunity in children

P. Kuna, D. Murrell, M. Gold, 2006, Archives of Disease in Childhood.

Risk of severe allergic reactions to COVID‐19 vaccines among patients with allergic skin diseases – practical recommendations. A position statement of ETFAD with external experts

C. Flohr, L. Klimek, J. Ring, 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases – practical recommendations. A position of

C. Flohr, L. Klimek, T. Bieber, 2021 .

Prevalence and impact of risk factors for poor asthma outcomes in a large, specialist-managed patient cohort: a real-life study

Z. Szalai, L. Tamási, V. Müller, 2019, Journal of asthma and allergy.

Role of differential scanning calorimetry (DSC) in the staging of COPD

D. Lőrinczy, Z. Szalai, T. Molnár, 2017, Journal of Thermal Analysis and Calorimetry.

Therapeutic Success of Tiotropium/Olodaterol, Measured Using the Clinical COPD Questionnaire (CCQ), in Routine Clinical Practice: A Multinational Non-Interventional Study

A. Valipour, J. Šorli, Z. Szalai, 2021, International journal of chronic obstructive pulmonary disease.

European Task Force on Atopic Dermatitis: position on vaccination of adult patients with atopic dermatitis against COVID‐19 (SARS‐CoV‐2) being treated with systemic medication and biologics

C. Flohr, J. Ring, T. Bieber, 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

PACAP Immunoreactivity in Human Malignant Tumor Samples and Cardiac Diseases

A. Tamas, D. Reglodi, B. Gaszner, 2012, Journal of Molecular Neuroscience.

Global Allergy Forum and 3rd Davos Declaration 2015

F. Chew, C. Akdis, J. Ring, 2016, Allergy.

Asthma Bridge warp Chronic sinusitis Chronic adenoids Figure 2 Proportion of moderate to severe allergic rhinitis patients with various concomitant diseases in Hungary

I. Horváth, M. Szilasi, Z. Szalai, 2013 .

A survey of the burden of allergic rhinitis in Hungary from a specialist’s perspective

I. Horváth, M. Szilasi, Z. Szalai, 2012, Multidisciplinary Respiratory Medicine.

Long-term follow-up in the KEYNOTE-010 study of pembrolizumab (pembro) for advanced NSCLC, including in patients (pts) who completed 2 years of pembro and pts who received a second course of pembro

R. Herbst, S. Novello, G. Ceresoli, 2018, Annals of Oncology.

European Task Force on Atopic Dermatitis (ETFAD): treatment targets and treatable traits in atopic dermatitis

C. Flohr, J. Ring, T. Bieber, 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

Avelumab in Combination With Cetuximab and Chemotherapy as First-Line Treatment for Patients With Advanced Squamous NSCLC

E. Felip, F. Ciardiello, G. Stojanović, 2023, JTO clinical and research reports.

Necrotizing fasciitis and toxic shock syndrome due to Streptococcus pyogenes in a female adolescent – A case report

Z. Szalai, P. Pázmány, L. Szabó, 2023, Journal of Pediatric Surgery Case Reports.

375O Final efficacy results from IMpower132: First-line atezolizumab + chemotherapy in patients with stage IV non-squamous NSCLC

M. Socinski, S. Novello, P. Dubray-Longeras, 2020 .

A long-term, prospective, observational cohort study of the safety and effectiveness of etanercept for the treatment of patients with paediatric psoriasis in a naturalistic setting

E. Brinkley, J. Largent, M. Ståhle, 2023, European Journal of Dermatology.

A Comparison of Psoriasis Severity in Pediatric Patients Treated With Methotrexate vs Biologic Agents.

D. West, K. Holland, J. Lambert, 2020, JAMA dermatology.

OA03.07 KEYNOTE-010: Durable Clinical Benefit in Patients with Previously Treated, PD-L1-Expressing NSCLC Who Completed Pembrolizumab

Y. Shentu, R. Herbst, H. Saka, 2017 .

Long-term survival in patients (pts) with advanced NSCLC in the KEYNOTE-010 study overall and in pts who completed two years of pembrolizumab (pembro).

R. Herbst, S. Novello, G. Ceresoli, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Superimposed Mosaicism in the Form of Extremely Extended Segmental Plexiform Neurofibroma Caused by a Novel Pathogenic Variant in the NF1 Gene

R. Happle, M. Garami, J. Bene, 2023, International journal of molecular sciences.

Co-occurrence of neurofibromatosis type 1 and pseudoachondroplasia – a first case report

J. Bene, T. Kalmár, Z. Szalai, 2023, BMC Pediatrics.

Human Papillomavirus Infection-Core Concepts

Z. Szalai, 2019 .

Efficacy and Safety of Abrocitinib in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis (AD): Results From the Phase 3 JADE TEEN study

C. Flohr, Hidetoshi Takahashi, G. Chan, 2021 .

Genetic dissection between coeliac disease and dermatitis herpetiformis in sib pairs.

I. Korponay-Szabó, M. Mäki, J. Partanen, 2002, Annals of Human Genetics.

Neoadjuvant Crizotinib for ALK Re-arranged NSCLC?

Z. Szalai, A. Szipőcs, T. Molnár, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.